Patents by Inventor Hee Jeong SHIN

Hee Jeong SHIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • bacteriophage Clo-PEP-2 and use for inhibiting proliferation of same
    Patent number: 11529406
    Abstract: The present invention relates to Siphoviridae bacteriophage Clo-PEP-2 (accession number KCTC 13185BP), separated from nature, which is capable of killing Clostridium perfringens and has a genome expressed by sequence number 1 and a method for preventing or treating diseases, induced by Clostridium perfringens, by means of a composition comprising the Siphoviridae bacteriophage Clo-PEP-2 as an active ingredient.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: December 20, 2022
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Hee Jeong Shin, Sang Hyeon Kang
  • bacteriophage pse-AEP-4 and use thereof for inhibiting proliferation of
    Patent number: 11497216
    Abstract: The present invention relates to Podoviridae bacteriophage Pse-AEP-4 (accession number: KCTC 13166BP) isolated from nature, the Podoviridae bacteriophage Pse-AEP-4 having the capability to specifically kill Pseudomonas aeruginosa and having a genome represented by SEQ ID NO: 1, and a method for preventing or treating diseases induced by Pseudomonas aeruginosa by using a composition containing the Podoviridae bacteriophage Pse-AEP-4 as an active ingredient.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: November 15, 2022
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Soo Youn Jun, Jee Soo Son, Hyoun Rok Paik, Hee Jeong Shin, Sang Hyeon Kang
  • bacteriophage Pse-AEP-3 and use thereof for inhibiting proliferation of
    Patent number: 11457635
    Abstract: The present invention relates to Podoviridae bacteriophage Pse-AEP-3 (accession number: KCTC 13165BP) isolated from nature, the Podoviridae bacteriophage Pse-AEP-3 having the capability to specifically kill Pseudomonas aeruginosa and having a genome represented by SEQ ID NO: 1, and a method for preventing or treating diseases induced by Pseudomonas aeruginosa by using a composition containing the Podoviridae bacteriophage Pse-AEP-3 as an active ingredient.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: October 4, 2022
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Soo Youn Jun, Jee Soo Son, Hyoun Rok Paik, Hee Jeong Shin, Sang Hyeon Kang
  • NOVEL CLOSTRIDIUM PERFRINGENS BACTERIOPHAGE CLO-PEP-2 AND USE FOR INHIBITING CLOSTRIDIUM PERFRINGENS PROLIFERATION OF SAME
    Publication number: 20200054042
    Abstract: The present invention relates to Siphoviridae bacteriophage Clo-PEP-2 (accession number KCTC 13185BP), separated from nature, which is capable of killing Clostridium perfringens and has a genome expressed by sequence number 1 and a method for preventing or treating diseases, induced by Clostridium perfringens, by means of a composition comprising the Siphoviridae bacteriophage Clo-PEP-2 as an active ingredient.
    Type: Application
    Filed: January 11, 2018
    Publication date: February 20, 2020
    Inventors: Seong Jun Yoon, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Hee Jeong Shin, Sang Hyeon Kang
  • NOVEL PSEUDOMONAS AERUGINOSA BACTERIOPHAGE PSE-AEP-3 AND USE THEREOF FOR INHIBITING PROLIFERATION OF PSEUDOMONAS AERUGINOSA
    Publication number: 20190359948
    Abstract: The present invention relates to Podoviridae bacteriophage Pse-AEP-3 (accession number: KCTC 13165BP) isolated from nature, the Podoviridae bacteriophage Pse-AEP-3 having the capability to specifically kill Pseudomonas aeruginosa and having a genome represented by SEQ ID NO: 1, and a method for preventing or treating diseases induced by Pseudomonas aeruginosa by using a composition containing the Podoviridae bacteriophage Pse-AEP-3 as an active ingredient.
    Type: Application
    Filed: January 11, 2018
    Publication date: November 28, 2019
    Inventors: Seong Jun Yoon, Soo Youn Jun, Jee Soo Son, Hyoun Rok Paik, Hee Jeong Shin, Sang Hyeon Kang
  • NOVEL PSEUDOMONAS AERUGINOSA BACTERIOPHAGE PSE-AEP-4 AND USE THEREOF FOR INHIBITING PROLIFERATION OF PSEUDOMONAS AERUGINOSA
    Publication number: 20190359949
    Abstract: The present invention relates to Podoviridae bacteriophage Pse-AEP-4 (accession number: KCTC 13166BP) isolated from nature, the Podoviridae bacteriophage Pse-AEP-4 having the capability to specifically kill Pseudomonas aeruginosa and having a genome represented by SEQ ID NO: 1, and a method for preventing or treating diseases induced by Pseudomonas aeruginosa by using a composition containing the Podoviridae bacteriophage Pse-AEP-4 as an active ingredient.
    Type: Application
    Filed: January 11, 2018
    Publication date: November 28, 2019
    Inventors: Seong Jun Yoon, Soo Youn Jun, Jee Soo Son, Hyoun Rok Paik, Hee Jeong Shin, Sang Hyeon Kang
  • Enterohemorrhagic bacteriophage Esc-CHP-1 and use thereof for inhibiting proliferation of enterohemorrhagic
    Patent number: 10265353
    Abstract: The present invention relates to a Myoviridae bacteriophage Esc-CHP-1 that is isolated from the nature and can kill specifically enterohemorrhagic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12660BP), and a method for preventing and treating the infections of enterohemorrhagic E. coli using the composition comprising said bacteriophage as an active ingredient.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: April 23, 2019
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Byung Kuk Kim, Hee Jeong Shin
  • Enteroinvasive bacteriophage Esc-COP-4 and use thereof for inhibiting proliferation of enteroinvasive
    Patent number: 10265356
    Abstract: The present invention relates to a Myoviridae bacteriophage Esc-COP-4 that is isolated from the nature and can kill specifically enteroinvasive E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12663BP), and a method for preventing and treating the infections of enteroinvasive E. coli using the composition comprising said bacteriophage as an active ingredient.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: April 23, 2019
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Byung Kuk Kim, Hee Jeong Shin, Dong Min Kang
  • Enteropathogenic bacteriophage Esc-CHP-2 and use thereof for inhibiting proliferation of enteropathogenic
    Patent number: 10265354
    Abstract: The present invention relates to a Myoviridae bacteriophage Esc-CHP-2 that is isolated from the nature and can kill specifically enteropathogenic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12661BP), and a method for preventing and treating the infections of enteropathogenic E. coli using the composition comprising said bacteriophage as an active ingredient.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: April 23, 2019
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Byung Kuk Kim, Hee Jeong Shin
  • bacteriophage Lac-PLP-1 and use thereof for inhibiting proliferation
    Patent number: 10227571
    Abstract: The present invention relates to a Siphoviridae bacteriophage Lac-PLP-1 that is isolated from the nature and can kill Lactobacillus plantarum cells specifically, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12665BP), and a method for preventing and treating the contaminations of Lactobacillus plantarum by using the composition comprising the bacteriophage as an active ingredient.
    Type: Grant
    Filed: January 5, 2016
    Date of Patent: March 12, 2019
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Jee Soo Son, Hyoun Rok Paik, Hee Jeong Shin
  • NOVEL LACTOBACILLUS PLANTARUM BACTERIOPHAGE LAC-PLP-1 AND USE THEREOF FOR INHIBITING LACTOBACILLUS PLANTARUM PROLIFERATION
    Publication number: 20180119109
    Abstract: The present invention relates to a Siphoviridae bacteriophage Lac-PLP-1 that is isolated from the nature and can kill Lactobacillus plantarum cells specifically, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12665BP), and a method for preventing and treating the contaminations of Lactobacillus plantarum by using the composition comprising the bacteriophage as an active ingredient.
    Type: Application
    Filed: January 5, 2016
    Publication date: May 3, 2018
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Jee Soo Son, Hyoun Rok Paik, Hee Jeong Shin
  • NOVEL ENTEROPATHOGENIC E. COLI BACTERIOPHAGE ESC-CHP-2 AND USE THEREOF FOR INHIBITING PROLIFERATION OF ENTEROPATHOGENIC E. COLI
    Publication number: 20170348365
    Abstract: The present invention relates to a Myoviridae bacteriophage Esc-CHP-2 that is isolated from the nature and can kill specifically enteropathogenic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12661BP), and a method for preventing and treating the infections of enteropathogenic E. coli using the composition comprising said bacteriophage as an active ingredient.
    Type: Application
    Filed: December 28, 2015
    Publication date: December 7, 2017
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Byung Kuk Kim, Hee Jeong Shin
  • NOVEL ENTEROHEMORRHAGIC E. COLI BACTERIOPHAGE ESC-CHP-1 AND USE THEREOF FOR INHIBITING PROLIFERATION OF ENTEROHEMORRHAGIC E. COLI
    Publication number: 20170333498
    Abstract: The present invention relates to a Myoviridae bacteriophage Esc-CHP-1 that is isolated from the nature and can kill specifically enterohemorrhagic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12660BP), and a method for preventing and treating the infections of enterohemorrhagic E. coli using the composition comprising said bacteriophage as an active ingredient.
    Type: Application
    Filed: December 28, 2015
    Publication date: November 23, 2017
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Byung Kuk Kim, Hee Jeong Shin
  • NOVEL ENTEROINVASIVE E. COLI BACTERIOPHAGE ESC-COP-4 AND USE THEREOF FOR INHIBITING PROLIFERATION OF ENTEROINVASIVE E. COLI
    Publication number: 20170333499
    Abstract: The present invention relates to a Myoviridae bacteriophage Esc-COP-4 that is isolated from the nature and can kill specifically enteroinvasive E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12663BP), and a method for preventing and treating the infections of enteroinvasive E. coli using the composition comprising said bacteriophage as an active ingredient.
    Type: Application
    Filed: December 28, 2015
    Publication date: November 23, 2017
    Inventors: Seong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Byung Kuk Kim, Hee Jeong Shin, Dong Min Kang
  • Underwater support concrete structure construction method
    Patent number: 9435096
    Abstract: Disclosed is a construction method of a foundation for an underwater support structure, which is capable of rapidly installing the foundation of a large-scale structure on a sea floor, and also sufficiently ensuring a horizontal load supporting capability. The construction method includes installing a pile having a head part, in which a catching groove is formed, in a sea floor G; fabricating the foundation for the underwater support structure, in which a buried guide tube is formed to protrude downwardly from a lower surface of the foundation for an underwater support structure, and settling the foundation for the underwater support structure on the sea floor, such that the head part of the pile is inserted into the guide tube; and anchoring the pile into the guide tube using an elastically protruding settlement device formed in the guide tube.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: September 6, 2016
    Assignee: DONG MYEONG ENGINEERING CONSULTANTS & ARCHITECTURE
    Inventors: Hee Jeong Shin, Young Jun Lee, Seong hwan Kim
  • UNDERWATER SUPPORT CONCRETE STRUCTURE CONSTRUCTION METHOD
    Publication number: 20160047107
    Abstract: Disclosed is a construction method of a foundation for an underwater support structure, which is capable of rapidly installing the foundation of a large-scale structure on a sea floor, and also sufficiently ensuring a horizontal load supporting capability. The construction method includes installing a pile having a head part, in which a catching groove is formed, in a sea floor G; fabricating the foundation for the underwater support structure, in which a buried guide tube is formed to protrude downwardly from a lower surface of the foundation for an underwater support structure, and settling the foundation for the underwater support structure on the sea floor, such that the head part of the pile is inserted into the guide tube; and anchoring the pile into the guide tube using an elastically protruding settlement device formed in the guide tube.
    Type: Application
    Filed: November 20, 2014
    Publication date: February 18, 2016
    Inventors: Hee Jeong SHIN, Young Jun Lee, Seong hwan Kim